Goldin JG - Search Results

1

Transitions to different patterns of interstitial lung disease in scleroderma with and without treatment.

Kim HJ, Tashkin DP, Gjertson DW, Brown MS, Kleerup E, Chong S, Belperio JA, Roth MD, Abtin F, Elashoff R, Tseng CH, Khanna D, Goldin JG. Kim HJ, et al. Among authors: goldin jg. Ann Rheum Dis. 2016 Jul;75(7):1367-71. doi: 10.1136/annrheumdis-2015-208929. Epub 2016 Jan 12. Ann Rheum Dis. 2016. PMID: 26757749 Clinical Trial.

2

Classification of parenchymal abnormality in scleroderma lung using a novel approach to denoise images collected via a multicenter study.

Kim HJ, Li G, Gjertson D, Elashoff R, Shah SK, Ochs R, Vasunilashorn F, Abtin F, Brown MS, Goldin JG. Kim HJ, et al. Among authors: goldin jg. Acad Radiol. 2008 Aug;15(8):1004-16. doi: 10.1016/j.acra.2008.03.011. Acad Radiol. 2008. PMID: 18620121 Free PMC article.

3

High-resolution CT scan findings in patients with symptomatic scleroderma-related interstitial lung disease.

Goldin JG, Lynch DA, Strollo DC, Suh RD, Schraufnagel DE, Clements PJ, Elashoff RM, Furst DE, Vasunilashorn S, McNitt-Gray MF, Brown MS, Roth MD, Tashkin DP; Scleroderma Lung Study Research Group. Goldin JG, et al. Chest. 2008 Aug;134(2):358-367. doi: 10.1378/chest.07-2444. Epub 2008 Jul 18. Chest. 2008. PMID: 18641099 Clinical Trial.

4

Predicting treatment outcomes and responder subsets in scleroderma-related interstitial lung disease.

Roth MD, Tseng CH, Clements PJ, Furst DE, Tashkin DP, Goldin JG, Khanna D, Kleerup EC, Li N, Elashoff D, Elashoff RM; Scleroderma Lung Study Research Group. Roth MD, et al. Among authors: goldin jg. Arthritis Rheum. 2011 Sep;63(9):2797-808. doi: 10.1002/art.30438. Arthritis Rheum. 2011. PMID: 21547897 Free PMC article. Clinical Trial.

5

Quantitative texture-based assessment of one-year changes in fibrotic reticular patterns on HRCT in scleroderma lung disease treated with oral cyclophosphamide.

Kim HJ, Brown MS, Elashoff R, Li G, Gjertson DW, Lynch DA, Strollo DC, Kleerup E, Chong D, Shah SK, Ahmad S, Abtin F, Tashkin DP, Goldin JG. Kim HJ, et al. Among authors: goldin jg. Eur Radiol. 2011 Dec;21(12):2455-65. doi: 10.1007/s00330-011-2223-2. Epub 2011 Sep 17. Eur Radiol. 2011. PMID: 21927793 Clinical Trial.

6

Longitudinal Changes in Quantitative Interstitial Lung Disease on Computed Tomography after Immunosuppression in the Scleroderma Lung Study II.

Goldin JG, Kim GHJ, Tseng CH, Volkmann E, Furst D, Clements P, Brown M, Roth M, Khanna D, Tashkin DP. Goldin JG, et al. Ann Am Thorac Soc. 2018 Nov;15(11):1286-1295. doi: 10.1513/AnnalsATS.201802-079OC. Ann Am Thorac Soc. 2018. PMID: 30265153 Free PMC article. Clinical Trial.

7

Using Transitional Changes on High-Resolution Computed Tomography to Monitor the Impact of Cyclophosphamide or Mycophenolate Mofetil on Systemic Sclerosis-Related Interstitial Lung Disease.

Kim GHJ, Tashkin DP, Lo P, Brown MS, Volkmann ER, Gjertson DW, Khanna D, Elashoff RM, Tseng CH, Roth MD, Goldin JG. Kim GHJ, et al. Among authors: goldin jg. Arthritis Rheumatol. 2020 Feb;72(2):316-325. doi: 10.1002/art.41085. Epub 2019 Dec 26. Arthritis Rheumatol. 2020. PMID: 31430058 Free PMC article.

8

A computer-aided diagnosis system for quantitative scoring of extent of lung fibrosis in scleroderma patients.

Kim HG, Tashkin DP, Clements PJ, Li G, Brown MS, Elashoff R, Gjertson DW, Abtin F, Lynch DA, Strollo DC, Goldin JG. Kim HG, et al. Among authors: goldin jg. Clin Exp Rheumatol. 2010 Sep-Oct;28(5 Suppl 62):S26-35. Epub 2010 Nov 3. Clin Exp Rheumatol. 2010. PMID: 21050542 Free PMC article. Clinical Trial.

9

The MUC5B promoter variant does not predict progression of interstitial lung disease in systemic sclerosis.

Volkmann ER, Tashkin DP, Roth MD, Li N, Charles J, Mayes M, Kim G, Goldin J, Pourzand L, Clements PJ, Furst DE, Khanna D, Elashoff RM, Assassi S. Volkmann ER, et al. Semin Arthritis Rheum. 2020 Oct;50(5):963-967. doi: 10.1016/j.semarthrit.2020.06.003. Epub 2020 Jun 16. Semin Arthritis Rheum. 2020. PMID: 32906032 Free PMC article. Clinical Trial.

10

Early Radiographic Progression of Scleroderma: Lung Disease Predicts Long-term Mortality.

Volkmann ER, Tashkin DP, Roth MD, Goldin J, Kim GHJ. Volkmann ER, et al. Chest. 2022 May;161(5):1310-1319. doi: 10.1016/j.chest.2021.11.033. Epub 2021 Dec 8. Chest. 2022. PMID: 34896093 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

239 results

Search Page

Filters